KOFU, JAPAN--October 2, 2024--Researched by Industrial Info Resources (Sugar Land, Texas)--KM Biologics Company Limited (Kumamoto, Japan) is expanding its bulk active pharmaceutical ingredient (API) single-use systems (SUS) plant in Kumamoto, Japan. The facility will increase its production of the "four-in-one" vaccine, the Japanese encephalitis vaccine and, when necessary, vaccines for pandemics.